Literature DB >> 8625969

Murine epidermal Langerhans cells do not express inducible nitric oxide synthase.

C Blank1, C Bogdan, C Bauer, K Erb, H Moll.   

Abstract

In Leishmania-infected macrophages (M phi), the formation of reactive nitrogen intermediates by the inducible isoform of nitric oxide synthase (iNOS) is critical for the killing of the intracellular parasites. We have recently shown that, in addition to M phi, epidermal Langerhans cells (LC) can phagocytose Leishmania major, but they do not allow parasite replication. Therefore, we analyzed whether LC and M phi display the same leishmanicidal effector mechanism. Unlike M phi, stimulation of unselected epidermal cells with interferon-gamma/lipopolysaccharide did not lead to the release of nitric oxide (NO), and inhibition of NO production had no effect on the rate of infection of LC. iNOS mRNA was clearly detectable in M phi as well as unselected epidermal cells (the majority of which consists of keratinocytes) after stimulation with different cytokines. In contrast, pure LC obtained by single-cell picking from cytokine-activated or L. major-infected epidermal cells did not express iNOS mRNA. Addition of the NO donor S-nitroso-N-acetylpenicillamine to already-infected LC did not alter their rate of infection, indicating that LC do not utilize exogenous NO for the control of intracellular Leishmania. These results suggest that in the L. major-infected skin, activated M phi and keratinocytes, but not LC have the ability to express iNOS activity. Therefore, an as yet unidentified, NO-independent mechanism appears to be responsible for the control of parasite replication in LC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625969     DOI: 10.1002/eji.1830260410

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Invasion and intracellular survival by protozoan parasites.

Authors:  L David Sibley
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

2.  Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major.

Authors:  S Flohé; T Lang; H Moll
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Amastigote load and cell surface phenotype of infected cells from lesions and lymph nodes of susceptible and resistant mice infected with Leishmania major.

Authors:  Eric Muraille; Carl De Trez; Bernard Pajak; Fabiola Aguilar Torrentera; Patrick De Baetselier; Oberdan Leo; Yves Carlier
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 4.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists.

Authors:  Dirk Werling; Jayne C Hope; Chris J Howard; Thomas W Jungi
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

6.  Rat bone marrow-derived dendritic cells, but not ex vivo dendritic cells, secrete nitric oxide and can inhibit T-cell proliferation.

Authors:  Timothy J Powell; Chris D Jenkins; Ryuichi Hattori; G Gordon MacPherson
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

7.  Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activation.

Authors:  Sylvie Bertholet; Harold L Dickensheets; Faruk Sheikh; Albert A Gam; Raymond P Donnelly; Richard T Kenney
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

8.  Characteristics of "Tip-DCs and MDSCs" and Their Potential Role in Leishmaniasis.

Authors:  Maximilian Schmid; Anja K Wege; Uwe Ritter
Journal:  Front Microbiol       Date:  2012-03-12       Impact factor: 5.640

9.  The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

Authors:  Y Belkaid; K F Hoffmann; S Mendez; S Kamhawi; M C Udey; T A Wynn; D L Sacks
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

10.  In situ cellular immune response in non-ulcerated skin lesions due to Leishmania (L.) infantum chagasi infection.

Authors:  Carmen Sandoval; Gabriela Araujo; Wilfredo Sosa; Sara Avalos; Fernando Silveira; Carlos Corbett; Concepción Zúniga; Marcia Laurenti
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-02-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.